Objectives: The objective of the present randomized controlled trial was to evaluate the efficacy of a mouthrinse containing a combination of AmF/SnF2 in controlling supragingival plaque accumulation and gingival inflammation during a 12-week period in patients affected by generalized aggressive periodontitis (GAP).
Methods: Eighteen subjects, six males and 12 females, mean age: 32.2 years, were evaluated.